(Nasdaq: BIIB), announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for a once-weekly lecanemab-irmb subcutaneous injection ...
Prompt injections, the malicious commands attackers embed into content to entice LLMs to follow them, have been attackers’ go ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results